Your trusted destination for CME, CPD & Medical Education across the Middle East.
The International Conference on Vaccines and Clinical Trials (ICVCT-26) is a hybrid event for researchers, scientists, and industry experts to exchange knowledge on the latest advancements in the field, covering topics from trial design and safety evaluation to regulatory affairs.
Join leading researchers, academicians, policymakers, and industry professionals at the International Conference on Vaccines and Clinical Trials (ICVCT-26). This hybrid conference provides a premier platform to share experiences, discuss cutting-edge research findings, and network with peers from around the globe. Attendees will have the opportunity to learn about the latest developments in vaccine research, from innovative trial designs to efficacy assessment and regulatory challenges. Whether attending in person or virtually, participants can engage in stimulating discussions, present their work, and contribute to the advancement of global health and well-being.
Exploring new approaches and frameworks for conducting more efficient and informative vaccine trials.
Discussion on the implementation and benefits of adaptive designs in vaccine development to accelerate outcomes.
Analyzing the role of real-world data and evidence in supplementing traditional clinical trial findings.
Strategies and challenges in post-licensure surveillance and long-term safety evaluation of vaccines.
Identifying and validating immune markers that predict vaccine-induced protection against disease.
Addressing the unique challenges of assessing vaccine efficacy in groups such as the elderly, immunocompromised, and pediatric populations.
Efforts and challenges in aligning regulatory requirements for vaccine approval across different countries and regions.
An overview of standard, accelerated, and emergency use authorization pathways for new vaccines.
Best practices for data management, statistical analysis, and ensuring data integrity in vaccine clinical trials.
Exploring advancements in mRNA, viral vector, and protein subunit vaccine technologies.
Innovations in vaccine adjuvants and novel delivery systems to enhance immunogenicity and effectiveness.
Discussing key ethical issues, including informed consent, placebo use, and equitable access in vaccine research.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow
